Skip to main content
. 2022 Apr 24;14(9):2128. doi: 10.3390/cancers14092128

Table 3.

Mechanistic aspects of glycosyltransferase action and regulation.

Enzyme Upstream Regulator(s) Downstream Pathways Cancer Tissue/Cell Line Effect *
ALG3 TGF-β receptor 2 Breast Stemness, radioresistance [94]
Heat shock factor 2 Breast Progression [95]
miR-98-5p Non-small cell lung Progression [5]
B3GNT3 RhoA/RAC1 Endometrial Progression [61]
miR-149-5p Lung Progression [62]
EGFR/PD-L1 Lung Immune escape [66]
EGF/PD1-PD-L1 Breast Immune escape [65]
B3GNT5 lncRNA MIR44352HG/miR1365p Liver Progression [96]
B3GNT7 Promoter methylation Colorectal Inhibition ** [57]
B4GALT3 lncRNA DANCR/miR-338-3p Neuroblastoma Progression [70]
β1-integrins Neuroblastoma Progression [71]
miR-27a β1-integrins Cervical Progression [73]
β1-integrins Colorectal Inhibition [74]
B4GALT5 Wnt/β-catenin Breast Stemness [44]
Circ_0009910/miR-491-5p PI3K/AKT Acute myeloid leukemia Progression [97]
B4GALNT1 JNK/c-Jun/Slug Lung Progression [47]
EGFR breast Stemness [50]
β1 integrins/FAK/SRC/ERK Glioblastoma, lung, kidney Progression [52]
GM2/GD2 Melanoma Angiogenesis, progression [51]
GALNT2 IGF-R1 Neuroblastoma Inhibition [98]
Met Gastric Inhibition [18]
EGFR Liver Inhibition [17]
EGFR/AKT Oral squamous Progression [12]
EGFR/PI3K/AKT/mTOR Glioma Progression [13]
Notch/Hes1-PTEN-PI3K/AKT Lung Progression [15]
GALNT10 DLGAP1-AS2/miR-505 Bile ducts Progression [20]
HNF4/miR-122 Liver Progression [21]
Histone methylation/ZBTB2 Ovary Stemness [99]
FUT7 EGFR/AKT/mTOR Lung Progression [88]
Promoter methylation Bladder Progression [90]
EGFR Thyroid Progression [91]
POFUT1 Notch Liver Progression [31,32]
Colorectal [28,29]
Glioblastoma [34]
ST3GAL4 Met, RON Gastric Progression [85,100,101]
Promoter methylation/GATA2 Ovary, Breast Progression [102,103]
miR-370 Colorectal Adhesion [104]
ST6GALNAC4 miR-429 Thyroid Progression [83]

* The indicated effect is positively related to the expression of the indicated glycosyltransferase. ** Inhibition indicates attenuation of the neoplastic phenotype.